Cambridge Equities, LP, 10% Owner at Sorrento Therapeutics, Inc. (SRNE), sold 39,672 shares at $5.87 ($233K) on 2016-06-15, disclosed to the SEC on 2016-06-17.
Open-market sale of $233k SRNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.87 | 19,836 | $116K | 50.0% |
| 2 | $5.87 | 19,836 | $116K | 50.0% |
| Total | $5.87 avg | 39,672 | $233K | 100% |
| Filing → |